Company profile
IsoSpec Analytics SA
Isospec Analytics SA develops and commercializes disruptive analytical technologies to enable biomarker discovery and accelerate pharmaceutical and biotech product development. The company currently provides research services in glycomics and metabolomics as a transition before commercializing analytical instruments and software tools. By combining infrared fingerprinting with machine learning, we provide our customers with the needed molecular intelligence to move forward with certainty.
Source: startup.ch
Highlights
Winner Venture Kick
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
